ORASURE TECHNOLOGIES, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ORASURE TECHNOLOGIES, INC (OSUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 119.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 38.00K shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-06-30 was 78.00K shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-03-31 was 95.00K shares, a 313.04% increase year-over-year.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 119.00K shares, a 42.79% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 208.00K shares, a 20.93% increase from fiscal 2023.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 172.00K shares, a 18.48% decline from fiscal 2022.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 211.00K shares, a 214.93% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 119.00K shares 10-K · filed 2026-03-09 | |||
| 2024-12-31 | 208.00K shares 10-K · filed 2025-03-07 | |||
| 2023-12-31 | 172.00K shares 10-K · filed 2024-03-11 | |||
| 2022-12-31 | 38.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 38.00K shares derived: sum of 2 quarters · filed 2023-03-03 | 116.00K shares derived: sum of 3 quarters · filed 2023-03-03 | 211.00K shares 10-K · filed 2023-03-03 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 78.00K shares derived: sum of 2 quarters · filed 2022-11-08 | 173.00K shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 78.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 173.00K shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | 95.00K shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 67.00K shares 10-K · filed 2022-03-01 | |||
| 2021-03-31 | 23.00K shares 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 64.00K shares 10-K · filed 2021-03-01 | |||
| 2020-03-31 | 14.00K shares 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 37.00K shares 10-K · filed 2020-03-02 | |||
| 2018-12-31 | 24.00K shares 10-K · filed 2019-02-28 | |||
| 2018-03-31 | 24.00K shares 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 46.00K shares 10-K · filed 2018-02-28 | |||
| 2017-03-31 | 19.00K shares 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 223.00K shares 10-K · filed 2018-02-28 | |||
| 2016-03-31 | 7.00K shares 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | 60.00K shares 10-K · filed 2018-02-28 | |||
| 2015-03-31 | 29.00K shares 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | 96.00K shares 10-K · filed 2017-03-14 | |||
| 2014-03-31 | 70.00K shares 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | 195.00K shares 10-K · filed 2016-03-14 | |||
| 2013-03-31 | 103.00K shares 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | 67.00K shares 10-K · filed 2015-03-12 | |||
| 2012-06-30 | 15.63K shares 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | 188.00K shares 10-K · filed 2014-03-14 | |||
| 2010-12-31 | 634.00K shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |